help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maruyama, T.
Right arrow Articles by Sabe, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maruyama, T.
Right arrow Articles by Sabe, H.
Endocrinology Vol. 140, No. 12 5982-5990
Copyright © 1999 by The Endocrine Society


ARTICLES

Tyrosine Phosphorylation and Subcellular Localization of Focal Adhesion Proteins during in Vitro Decidualization of Human Endometrial Stromal Cells

Tetsuo Maruyama1, Yasunori Yoshimura and Hisataka Sabe2

Department of Obstetrics and Gynecology, Keio University School of Medicine (T.M., Y.Y.), Tokyo 160-0016, Japan; and the Department of Biological Responses, Institute for Virus Research, Kyoto University (T.M., H.S.), Kyoto 606-8397, Japan

Address all correspondence and requests for reprints to: Dr. Tetsuo Maruyama, Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-0016, Japan. Fax: 81-3-3226-1667.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Human endometrial stromal cells undergo in vitro decidualization when treated with progesterone and estrogen. Using this model, we previously reported specific changes in the c-Src kinase activity and tyrosine phosphorylation of several proteins during in vitro decidualization. Focal adhesion kinase (FAK) and paxillin are known to form a complex with c-Src at the focal contacts and to participate in the integrin-mediated signal transduction as c-Src substrates. We here examined the tyrosine phosphorylation and subcellular localization of the focal adhesion proteins in stromal cells isolated from human endometrium. We found, however, that the total levels of FAK and paxillin tyrosine phosphorylation were not markedly changed during decidualization or after steroid withdrawal. In our culture system, numerous multicellular nodules were developed in cultures of decidualized stromal cells, within whose nodules the focal contacts were found to disappear. Moreover, disruption of the focal contacts was accompanied by disorganization of the actin-based cytoskeleton. These findings suggest that tyrosine phosphorylation of the endometrial paxillin and FAK is not tightly regulated by the kinase activity of c-Src during in vitro decidualization. The escape from regulation by c-Src may be in part due to the dissociation of the focal adhesion proteins/c-Src complex caused by the breakdown of the focal adhesion plaques as well as the loss of the actin-based cytoskeletal architecture.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
INTEGRINS, a family of cell surface {alpha}ß heterodimeric transmembrane glycoprotein receptors, are one of the structural components of focal adhesions that are sites of tight adhesion to the underlying extracellular matrix (ECM) (1, 2). The aggregation of integrins upon cell to ECM attachment activates the focal adhesion kinase (FAK) and leads to the assembly of a multicomponent signaling complex including vinculin, {alpha}-actinin, paxillin, cortactin, talin, and tensin (2, 3, 4, 5). Src family tyrosine kinases such as c-Src and Fyn, which are also included in the focal adhesion complex, participate in this integrin-mediated signal transduction. These kinases modulate the activity and recruitment of the focal adhesion proteins and eventually affect the actin-based cytoskeletal organization (2, 3, 4, 5). Alterations in integrin-mediated cell adhesion to the ECM are essential regulatory processes during development, cell growth and differentiation, migration, apoptosis, and oncogenesis (1).

Recently, integrins have been implicated in a variety of biological processes in reproduction (6, 7, 8). Various types of integrins are temporally and spatially expressed in the endometrium during the implantation window (9, 10) and in the embryo and the surrounding trophoblast (11). Additionally, the inhibitory effects of antiintegrin antibodies on embryo attachment and outgrowth onto the endometrium (12, 13) indicate a pivotal role of integrins in implantation. Also, integrins may be involved in endometrial tissue remodeling by regulating the integrity of cell to cell and/or cell to ECM interaction (7, 8). For example, integrin ß1 is preferentially expressed in the pregnancy decidua in vivo, and its expression level is increased during in vitro decidualization of endometrial stromal cells (ESC) (8, 10, 14), suggesting the importance of integrin ß1 in decidual transformation. However, the role of integrins and focal adhesion proteins in decidualization remains unclear.

We previously reported that the kinase activity of c-Src is elevated and accompanied by changes in tyrosine phosphorylation of several cellular proteins during in vitro decidualization (15). Focal adhesion proteins, including FAK and paxillin, are deeply involved in the integrin-mediated signal transduction through focal adhesion assembly, serving as substrates for the Src family tyrosine kinases (2, 3, 4, 5). This knowledge prompted us to determine whether activation of an integrin-mediated signaling pathway(s) using FAK and paxillin is a downstream event of the decidual c-Src activation. Endometrial cells differentially express many types of integrins in the process of decidualization (8, 10, 14). Moreover, human and rodent ESC up- and down-regulate various types of ECM during in vivo and in vitro decidualization (16, 17, 18, 19, 20), thereby changing the composition of cell to cell and cell to ECM adherence. Taken together, it is likely that alterations in ECM components may activate decidualization-specific signaling cascades involving c-Src and focal adhesion proteins through ECM/integrin interaction, ultimately leading to the morphological and functional decidual transformation. Therefore, to investigate the c-Src-mediated signaling pathway responsible for decidualization, we here focused on analyzing tyrosine phosphorylation and subcellular localization of focal adhesion proteins such as paxillin and FAK.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Antibodies
Antiphosphotyrosine antibody 4G10 (mouse, monoclonal) and Z-PY1 (rabbit, polyclonal) were obtained from Upstate Biotechnology, Inc. (Lake Placid, NY) and Zymed Laboratories, Inc. (South San Francisco, CA), respectively. Antipaxillin monoclonal antibody was purchased from Transduction Laboratories, Inc. (Lexington, KY). Antivinculin antibody was obtained from Sigma Chemical Co. (St. Louis, MO). Fluorescein isothiocyanate (FITC)-conjugated phalloidin was purchased from Molecular Probes, Inc. (Eugene, OR). Anti-FAK polyclonal antibody was raised against the glutathione-S-transferase-fused C-terminal one third region of mouse FAK as described previously (21).

Isolation of ESC and hormonal treatment
Human endometria were obtained as described previously (15, 22). Three additional endometria obtained from premenopausal women without any history of gynecological malignancy were subjected to FAK and paxillin immunoprecipitation and immunocytochemical studies. Informed consent was obtained from all subjects.

Isolation and hormonal treatment of ESC were performed as previously described (15, 22). In brief, isolated ESC were cultured and grown to subconfluence in the basal medium: phenol red-free RPMI 1640 supplemented with 10% charcoal-stripped FCS and 1% antibiotic-antimycotic mixture (Life Technologies, Inc., Grand Island, NY). After 2 days of preculture, the medium was replaced with fresh basal medium containing 10 nM 17ß-estradiol (E2), 1 µM progesterone (P), 10 nM E2 plus 1 µM P, or 0.1% ethanol as control vehicles. The culture medium containing the hormones was renewed every 2 days. For hormone withdrawal experiments, ESC that had been treated with E2 and P for 14 days were washed and cultured with or without E2 and P for an additional 4 days.

Immunoprecipitation and immunoblotting with antiphosphotyrosine, paxillin, and FAK antibodies
Cell lysates were prepared with radioimmunoprecipitation buffer as previously described (15, 22). The protein concentration of the samples was measured by the DC protein assay kit (Bio-Rad Laboratories, Inc., Cambridge, MA). Immunoprecipitation and Western immunoblotting were performed as previously described (15). In brief, 100–200 µg cell lysates were immunoprecipitated by incubation with paxillin or FAK antibody for 120 min at 4 C, followed by addition of 20 µl protein G-Sepharose beads (Sigma Chemical Co.) for 60 min. Immune complexes were washed three times with radioimmunoprecipitation buffer and then resuspended in 2 x SDS sample buffer. The samples were subjected to SDS-PAGE, transferred to Immobilon (Millipore Corp., Bedford, MA), and detected by incubating the blots with the specified antibody. Immunoblots were incubated with either goat antirabbit or antimouse horseradish peroxidase-conjugated antibodies and developed using an enhanced chemiluminescence kit according to the manufacturer’s procedure (Amersham Pharmacia Biotech, Arlington Heights, IL). When indicated, immunoblots were stripped in the buffer [62.5 mM Tris (pH 6.8), 2% SDS, and 100 mM ß-mercaptoethanol] at 50 C for 30 min and reprobed with another specific antibody.

Immunofluorescence and confocal laser microscopy
The isolated ESC, obtained as previously described (15, 22), were seeded and grown on plastic chamber slides (Permanox, Lab-Tek Chamber Slide, Nunc, Roskilde, Denmark) to subconfluence. Subsequently, the cells were treated with or without E2 and/or P for 7 days. Cells were then fixed in 3.7% formaldehyde in PBS for 20 min at room temperature and permeablized with 0.5% Triton X-100 in PBS at room temperature. After they were blocked by 10% FCS in PBS for 30 min at room temperature, slides were incubated with either antipaxillin (1:250) or antivinculin antibody (1:400) for 90 min at 37 C. After being washed three times in PBS, bound antibodies were visualized using fluorescein-conjugated antibody for 30 min at 37 C in a moist chamber. For double staining of filamentous actin (F-actin) and either paxillin or vinculin, fluorescein-conjugated phalloidin was included with a secondary rhodamine-conjugated antimouse antibody. The slides were washed extensively in PBS and mounted. The confocal images as shown in Fig. 4Go were collected with a laser scanning microscope system (LSM-GB, Olympus Corp., Tokyo, Japan), as described previously (23, 24), under the following conditions: object lens, Olympus Corp. Splan-Apo x60 (numerical aperture = 1.4); zoom ratio, x 2.0. The other confocal images as shown in Fig. 5Go were taken using the MRC-600 Laser Scanning Confocal Imaging System (Bio-Rad Laboratories, Inc., Cambridge, MA) connected to a Carl Zeiss Axiplan compound microscope (New York, NY).



View larger version (87K):
[in this window]
[in a new window]
 
Figure 4. Disappearance of the focal contacts in the decidualization-induced multicellular nodules. Isolated ESC treated with control vehicles (A), E2 (B), P (C), or E2 plus P (D and E) for 7 days were immunostained with antipaxillin antibody. The first antibody was visualized by FITC-conjugated secondary antibody. The laser scanning confocal microscopy (Olympus Corp. LSM-GB) optically sectioned labeled multicellular nodules in cultures of decidualized ESC. The panel of focus in D was toward the substratum of the nodules, whereas the section shown in E was taken at the middle of nodules as indicated. Bars, 25 µm.

 


View larger version (70K):
[in this window]
[in a new window]
 
Figure 5. Disorganization of actin-based cytoskeleton in the decidualization-induced multicellular nodules. Isolated ESC treated with or without E2 and P as indicated for 7 days were double stained for F-actin using FITC-conjugated-phalloidin and for either paxillin or vinculin using the corresponding monoclonal antibody that was subsequently visualized by rhodamine-conjugated secondary antibody. A, Paxillin (upper left panel), F-actin (middle left panel), and both merged immunostaining (lower left panel) in the multicellular nodules developed during E2- and P-induced decidualization. The two right panels showed double labeled immunostaining for F-actin and paxillin in the untreated ESC. Bars in the left panels, 50 µm. Magnification in the two right panels, x1000. B, Vinculin (two upper panels), F-actin (two middle panels), and both merged immunostaining (two lower panels) in the multicellular nodules developed during E2- and P-induced decidualization (three left panels) vs. that in the untreated ESC (three right panels). The two micrographs in the right panels in A were taken using the conventional immunofluorescence microscope, whereas all other photographs in A and B were taken using the MRC-600 Laser Scanning Confocal Imaging System (Bio-Rad Laboratories, Inc.). Bars in the left and right panels, 50 and 25 µm, respectively.

 

    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
No marked alterations in tyrosine phosphorylation levels of paxillin and FAK during decidualization
To understand how the activation of c-Src is involved in decidualization in vitro, we examined tyrosine phosphorylation of paxillin and FAK, which are known to be in vivo and in vitro substrates for c-Src (2, 3, 4, 5). As shown in Fig. 1AGo, the whole pattern of tyrosine phosphorylation of cellular proteins was changed during E2- and P-induced decidualization as reported previously (15). A thick approximately 60-kDa band was clearly observed in ESC treated with control vehicles throughout the culture period (Fig. 1AGo, upper panel, lanes 1, 3, and 13, white arrowheads), whereas the intensity of this band was decreased as ESC underwent decidualization (Fig. 1AGo, upper panel, lanes 2, 4, and 15). In contrast, an approximately 56-kDa band whose tyrosine phosphorylation was not detected in undifferentiated ESC (Fig. 1AGo, upper panel, lanes 1, 3, and 13), became phosphorylated during decidualization (upper panel, lanes 2, 4, and 15, gray arrowheads). It remains to be solved whether each band of several tyrosine-phosphorylated proteins, including the approximately 60- and 56-kDa proteins represents a single protein. However, we previously provided strong evidence suggesting that the dephosphorylated, approximately 60-kDa band is c-Src (15).



View larger version (66K):
[in this window]
[in a new window]
 
Figure 1. Tyrosine phosphorylation of FAK and paxillin in the hormonally treated ESC. A, Immunoblotting data of whole cell lysates derived from hormonally treated ESC and immunoprecipitates with anti-FAK or antipaxillin antibody. Isolated ESC were treated with control vehicles (Cx; lanes 1, 3, 5, 7, 9, 11, 13, 16, and 19), E2 (lanes 14, 17, and 20), or E2 plus P (lanes 2, 4, 6, 8, 10, 12, 15, 18, and 21) for 3 days (lanes 1, 2, 5, 6, 9, and 10), 7 days (lanes 3, 4, 7, 8, 11, and 12), and 14 days (lanes 13–21), and then the cells were harvested. Whole cell lysates were prepared, and immunoprecipitation was performed as described in Materials and Methods. The cell lysates (Input: lanes 1–4 and 13–15) and immunoprecipitates with either anti-FAK antibody (IP: anti-FAK; lanes 9–12 and 19–21) or antipaxillin antibody (IP: anti-paxillin; lanes 5–8 and 16–18) were subjected to SDS-PAGE and immunoblotting with antiphosphotyrosine antibody 4G10 (anti-PY; upper panel). Blots were stripped and reprobed with anti-FAK antibody (middle panel), and then stripped again and reprobed with antipaxillin antibody (lower panel). White arrowheads, Tyrosine-phosphorylated, approximately 60-kDa protein(s); gray arrowheads, tyrosine-phosphorylated, approximately 56-kDa protein(s); black arrowheads, IgG heavy chains; gray arrows, tyrosine-phosphorylated paxillin; black arrows, tyrosine-phosphorylated FAK. The depicted blot is representative of similar three independent experiments using different endometrial samples including two samples used in the previous study (15 ). B, Immunoblotting data of whole cell lysates and paxillin immunoprecipitates derived from hormonally treated ESC as indicated. Blots were stripped and reprobed with antipaxillin antibody (lower panel) after the first blot with anti-PY antibody Z-PY1 (upper panel). Gray arrows, Tyrosine-phosphorylated paxillin. A total of two independent similar experiments were conducted, and the results from one representative experiment are shown.

 
Despite the alterations in the entire pattern of tyrosine phosphorylation, no dramatic changes in phosphorylation were seen in the 125-kDa FAK immunoprecipitates upon hormonal treatment (Fig. 1AGo, upper panel, lanes 9–12 and 19–21, black arrows). The intensity of the phosphorylation signal appeared to correlate with the protein amount of the corresponding immunoprecipitate (Fig. 1AGo, lanes 9–12 and 19–21 in upper panel vs. middle panel). The level of FAK expression was clearly constant throughout the culture (Fig. 1AGo, middle panel, lanes 1–4 and 13–15).

Similarly, the phosphorylation level of the 68-kDa paxillin immunoprecipitate was almost constant throughout the culture period (Fig. 1AGo, upper panel, lanes 5–8 and 16–18, gray arrows). Although the level of paxillin expression appeared to slightly increase during decidualization (Fig. 1AGo, lower panel, compare lane 1 with 2 and lane 13 with 15), no significant induction of paxillin was observed in the other two independent sets of similar experiments (Fig. 1BGo, lower panel, lanes 9–12; data not shown). In the lower panel of Fig. 1AGo, the signals of some paxillin immunoprecipitates were weak (lanes 7, 8, and 18), which might be caused by partial disruption of the paxillin blots from the membrane due to the repeated stripping and reprobing procedure. To further investigate the phosphorylation level of paxillin in hormonally treated ESC, the other independent set of similar experiments was performed as shown in Fig. 1BGo. These results clearly demonstrated that the phosphorylation levels of the paxillin immunoprecipitates (Fig. 1BGo, upper panel, lanes 1–8 and 13–16, gray arrows) and the protein amount of the immunoprecipitable paxillin (lower panel, lanes 1–8 and 13–16) were not markedly changed upon hormonal treatment and thereafter during decidualization. E2 alone did not provoke any change in the whole pattern of tyrosine phosphorylation or in the phosphorylation levels of FAK and paxillin (Fig. 1AGo, lanes 14, 17, and 20; Fig. 1BGo, lanes 2, 6, and 14), compared with the control treatment (Fig. 1AGo, lanes 13, 16, and 19; Fig. 1BGo, lanes 1, 5, and 13).

No marked alterations in tyrosine phosphorylation levels of paxillin and FAK upon steroid withdrawal
We previously reported that withdrawal of both estrogen and progesterone from cultures of decidualized ESC reduces c-Src kinase activity to the basal level, concomitantly reversing the tyrosine phosphorylation pattern to the unstimulated state (15). As FAK and paxillin are downstream targets of c-Src (2, 3, 4, 5), we further determined whether tyrosine phosphorylation of FAK and paxillin was changed in response to steroid withdrawal. As shown in Fig. 2Go, phosphorylated, approximately 64- and 56-kDa bands disappeared upon steroid withdrawal (upper panel, lanes 1 and 2, gray arrowheads), whereas the approximately 60-kDa band became phosphorylated (upper panel, lanes 1 and 2, white arrowheads). These changes in the whole pattern of tyrosine phosphorylation are consistent with the previous results (15). Although the phosphorylation signals of FAK and paxillin immunoprecipitates seemed to become weak upon steroid withdrawal (Fig. 2Go, upper panel, lanes 3–6), the decrease in the phosphorylation level correlated with that in the protein amount of the corresponding immunoprecipitates (middle panel, lanes 5 and 6; lower panel, lanes 3 and 4). Thus, steroid withdrawal also did not markedly affect the tyrosine phosphorylation status of FAK and paxillin.



View larger version (52K):
[in this window]
[in a new window]
 
Figure 2. Tyrosine phosphorylation of FAK and paxillin upon steroid withdrawal. Isolated ESC were treated with E2 and P for 14 days to allow them to become fully decidualized. Subsequently, the cells were washed, cultured with or without E2 and P for further 4 days (E2 + P and Withdrawal, respectively), and then harvested. Whole cell lysates were prepared, and immunoprecipitation with either antipaxillin or anti-FAK antibody was performed as described in Materials and Methods. The samples were subjected to SDS-PAGE and immunoblotting with 4G10 (upper panel). Blots were stripped and reprobed with anti-FAK antibody (middle panel) and thereafter again stripped and reprobed with antipaxillin antibody (lower panel). Gray arrowheads, Tyrosine-phosphorylated, approximately 64-kDa and approximately 56-kDa proteins; white arrowhead, tyrosine-phosphorylated, approximately 60-kDa protein(s); black arrowheads, IgG heavy chains; gray arrow, tyrosine-phosphorylated paxillin; black arrow, tyrosine-phosphorylated FAK. A total of two independent similar experiments were conducted using two different endometrial samples, including one used in the previous study (15 ), and the result from one representative experiment is shown.

 
Development of numerous multicellular nodules during in vitro decidualization
In our culture system, untreated ESC remain flattened throughout the duration of the cultures (Fig. 3AGo). In contrast, E2- plus P-treated ESC became rounded and densely packed, and gave rise to multicellular nodules (Fig. 3BGo). As shown in the phase contrast micrographs under the lower magnification (Fig. 3Go, C and D), numerous nodules were dominant in cultures of decidualized ESC (Fig. 3DGo), whereas no apparent nodules were observed in the control cultures (Fig. 3CGo).



View larger version (142K):
[in this window]
[in a new window]
 
Figure 3. Development of numerous multicellular nodules during in vitro decidualization of ESC. Phase contrast micrographs of isolated ESC cultured for 14 days with control vehicles (A and C) or with E2 and P (B and D). Photographs were taken under x100 magnification (A and B) and x40 magnification (C and D).

 
Loss of focal adhesion plaques in the decidualization-induced multicellular nodules
The formation of focal adhesions is prerequisite for the integrin-mediated signaling pathways responsible for cell growth, differentiation, migration, transformation, and contractility (2, 3, 5). To address the question of why tyrosine phosphorylation of FAK and paxillin was not markedly changed despite decidual c-Src activation, we next analyzed the subcellular localization of the focal adhesion proteins focusing on the characteristic decidualization-induced multicellular nodules. ESC in the control cultures clearly possessed focal contacts, as assessed by the immunostaining of paxillin and vinculin (Figs. 4AGo and 5AGo, two right panels; and Fig. 5BGo, three right panels). Although E2 or P alone induced cell aggregation to some extent, accumulation of paxillin in the focal adhesion plaques was not decreased (Fig. 4Go, B and C, respectively). The occasional monolayer populations of E2- and P-treated ESC, located between the multicellular nodules, also exhibited focal adhesions containing paxillin and vinculin (data not shown). However, in the multicellular nodules no discrete accumulations of paxillin staining could be detected at borders of adjoining cells or at distinct focal adhesion plaques; rather, paxillin was diffusely localized in the cytosol (Fig. 4EGo). However, in contrast, paxillin was localized in the focal contacts in the substratum of those nodules (Fig. 4DGo).

Disorganization of actin-based cytoskeleton in the decidualization-induced multicellular nodules
The orderly recruitment and complex formation of focal adhesion proteins are crucial for actin-based cytoskeletal organization (2, 3, 4, 5). We further investigated the subcellular distribution of actin stress fibers in the multicellular nodules where the formation of the focal adhesion assembly was impaired. Double labeled immunostaining of ESC using FITC-conjugated phalloidin and antipaxillin antibody, visualized by rhodamine-conjugated secondary antibody, showed that the undifferentiated and flattened ESC in the control cultures clearly possessed focal adhesion contacts containing paxillin (Fig. 5AGo, two right panels, yellow signals). Moreover, there were well stretched actin stress fibers (Fig. 5AGo, two right panels, green signals) linking paired focal adhesion contacts (white arrows). However, neither the typical subcellular distribution of paxillin nor F-actin connecting focal adhesion plaques could be detected within the multicellular nodules (Fig. 5AGo, left upper and middle panels, respectively). The merged image showed considerable yellow signals mainly at borders of adjoining cells (Fig. 5AGo, lower left panel). Although it may suggest the codistribution of some populations of cytosolic paxillin with F-actin, it remains to be clarified whether the merged signals were due to a real colocalization or a to simple overlapping of both signals at the cell periphery. Similarly, in the undifferentiated ESC, vinculin staining was observed at the focal contacts (Fig. 5BGo, upper right panel) with actin stress fibers (middle right panel) connecting vinculin-containing focal adhesion plaques (lower right panel, yellow signals). In the decidualization-induced multicellular nodules, however, vinculin did not localize at distinct focal contacts (Fig. 5BGo, upper left panel), but was diffusely localized in the cytosol (lower left panel, red signals) and also localized at the cell periphery along with F-actin (lower left panel, yellow signals).


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The current paradigm of integrin/ECM-mediated signaling is that the aggregation of integrins upon cell adhesion results in FAK autophosphorylation, followed by the recruitment of Src/Fyn or Csk through binding to the SH2 domains of these kinases (2). This complex, in turn, phosphorylates paxillin on multiple sites, leading to activation of the downstream signaling cascade (2). Src family tyrosine kinases bound to FAK phosphorylate additional sites in FAK and thereby stimulate FAK kinase activity (2, 4). Thus, Src family tyrosine kinases act as potential regulators of the integrin-mediated signal transduction involving FAK and paxillin at the focal contacts (2, 4).

In our culture system, the levels of FAK and paxillin phosphorylation appeared to be constant during decidualization and thereafter upon steroid withdrawal. Given our previous results showing activation of c-Src during in vitro decidualization and its inactivation upon steroid withdrawal (15), our present findings suggest that tyrosine phosphorylation of FAK and paxillin may not be related to the kinase activity of c-Src in decidualized ESC. This is in agreement with the report by Schlaepfer et al., who demonstrated that the activation of c-Src can be dissociated from FAK activation (25) and that there are at least two separate downstream pathways (25). This model may account for the c-Src-independent phosphorylation of the endometrial FAK and paxillin as presented here. In addition, c-Src interaction with FAK is known to be regulated by cell adhesion (5). Given the observed breakdown of focal adhesion contacts in decidualized ESC, it seems that dissociation of the c-Src/FAK focal adhesion complex may take place during decidualization. Thus, FAK and paxillin are no longer regulated by activated c-Src.

In contrast to the c-Src-FAK interaction, the paxillin-FAK interaction has been reported to be constitutive and unaffected by integrin-ECM interaction, i.e. the formation of focal adhesions (26). FAK is believed to be a point of convergence in the actions of integrins and growth factors (27, 28). In fact, FAK is not only activated by integrins, but also by mitogenic neuropeptides (29), thrombin (30), and ligands for tyrosine kinase receptors, such as platelet-derived growth factor and hepatocyte growth factor (31, 32, 33). As ESC produce a large number of growth factors during decidualization (34, 35), it is possible that tyrosine phosphorylation of the decidual FAK and paxillin may be regulated mainly by decidualization-associated growth factors rather than by integrin/c-Src-mediated signaling pathways. In this regard, decidualization might provoke a stepwise transition from integrin mediated- to growth factor-dependent signaling pathway(s) upstream of FAK and paxillin. This hypothesis may account for the constant levels of FAK and paxillin phosphorylation during decidualization despite the disruption of focal adhesions.

We have shown for the first time that there is a disorganization of the actin-based cytoskeleton and a loss of focal adhesions within the decidualization-associated multicellular nodules. The mechanism for this disruption is unknown. In fibroblasts, activation of the cAMP/PKA-mediated signaling pathway is known to disrupt focal adhesion plaques as well as the actin-based cytoskeleton through down-regulation of myosin light chain kinase (2, 36). Given that activation of the cAMP/PKA pathway is one of the key events associated with decidualization (37, 38, 39), this pathway may contribute to the decidualization-induced disruption of the cytoskeleton. Carter et al. reported that F-actin is reversibly disrupted in human ESC expressing the temperature-sensitive simian virus 40 large T antigen (40). Moreover, coexpression together with EJ ras oncogene results in the localized reorganization of stress fibers near the cell periphery (40). This pattern of subcellular F-actin distribution appears to be similar, as observed here within decidualization-induced multicellular nodules, in that F-actin was concentrated at the cell periphery. Similar localization of actin microfilaments at the cell periphery has been reported in a mouse in vitro decidualization model (20). It is, therefore, of great interest to determine whether the process of decidualization may involve Ras or Ras-related proteins such as Rho (2), a small GTP-binding protein potentially regulating the focal adhesion assembly and organization of the actin-based cytoskeleton (2).

Recently, Kim et al. reported that cytochalasin D-induced disruption of the actin-based cytoskeleton results in increased expression of insulin-like growth factor-binding protein-1, a typical decidualization-associated marker (41). They proposed the hypothesis that alterations in the cytoskeleton are deeply involved in insulin-like growth factor-binding protein-1 regulation (41). Although treatment of ESC with cytochalasin D is artificial, our data support the idea, in that breakdown of the cytoskeleton occurring during in vitro decidualization together with the loss of focal contacts may enhance the production of many bioactive substances by ESC. The coincidence of the production of decidualization-associated markers and the initiation of morphological decidual changes (15, 22, 42) also suggests a possible involvement of the cytoskeletal organization in decidual function.

The present study is the first to follow the tyrosine phosphorylation and subcellular distribution of focal adhesion proteins in hormonally treated human ESC in vitro. Together with our previous result indicating the elevation of c-Src kinase activity during in vitro decidualization (15), our present data suggest that c-Src may activate a different signaling pathway(s), which does not involve FAK and paxillin, in decidualized ESC. Furthermore, it is possible that dissociation of the focal adhesion complex together with breakdown of the actin-based cytoskeleton might actively contribute to both functional and morphological decidualization. In this regard, it is conceivable that cytosolic free forms of focal adhesion proteins may play a functional role in decidual transformation. Thus, further investigation focusing on the endometrial integrins, focal adhesion proteins, Src family tyrosine kinases, and actin-based cytoskeleton will help us understand the molecular mechanism underlying decidualization in vivo and in vitro.\.


    Acknowledgments
 
We are grateful to Dr. Tetsuro Takamatsu, Department of Pathology and Cell Regulation, Kyoto Prefectural Medical School, for his technical support and allowing us to access the confocal laser scanning microscope (Olympus Corp. LSM-GB) in his laboratory. We are greatly indebted to Dr. Valerie Horn for her critical reading of this manuscript. Special thanks are given to Dr. Junji Yodoi for his encouragement and generous support. We deeply thank Dr. Yuki Kitaoka and his colleagues, Department of Obstetrics and Gynecology, Kyoto National Hospital, for their cooperation in collecting tissue samples.


    Footnotes
 
1 Present address: Laboratory of Molecular Growth Regulation (T.M.), National Institute of Child Health and Human Development, National Institutes of Health, Building 6, Room 2A11, Bethesda, Maryland 20892. Back

2 Present address: Department of Molecular Biology (H.S.), Osaka Bioscience Institute, Furuedai, Suita, Osaka 565-0874, Japan. Back

Received May 3, 1999.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Hynes RO 1992 Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11–25[CrossRef][Medline]
  2. Burridge K, Chrzanowska-Wodnicka M 1996 Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 12:463–518[CrossRef][Medline]
  3. Yamada KM, Miyamoto S 1995 Integrin transmembrane signaling and cytoskeletal control. Curr Opin Cell Biol 7:681–689[CrossRef][Medline]
  4. Thomas SM, Brugge JS 1997 Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13:513–609[CrossRef][Medline]
  5. Hanks SK, Polte TR 1997 Signaling through focal adhesion kinase. BioEssays 19:137–145[CrossRef][Medline]
  6. Damsky C, Sutherland A, Fisher S 1993 Extracellular matrix 5: adhesive interactions in early mammalian embryogenesis, implantation, and placentation. FASEB J 7:1320–1329[Abstract]
  7. Sueoka K, Shiokawa S, Miyazaki T, Kuji N, Tanaka M, Yoshimura Y 1997 Integrins and reproductive physiology: expression and modulation in fertilization, embryogenesis, and implantation. Fertil Steril 67:799–811[CrossRef][Medline]
  8. Yoshimura Y, Miyakoshi K, Hamatani T, Iwahashi K, Takahashi J, Kobayashi N, Sueoka K, Miyazaki T, Kuji N, Tanaka M 1998 Role of ß1 integrins in human endometrium and decidua during implantation. Horm Res [Suppl 2] 50:46–55
  9. Lessey BA, Damjanovich L, Coutifaris C, Castelbaum A, Albelda SM, Buck CA 1992 Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle. J Clin Invest 90:188–195
  10. Shiokawa S, Yoshimura Y, Nagamatsu S, Sawa H, Hanashi H, Oda T, Katsumata Y, Koyama N, Nakamura Y 1996 Expression of ß1 integrins in human endometrial stromal and decidual cells. J Clin Endocrinol Metab 81:1533–1540[Abstract]
  11. Sutherland AE, Calarco PG, Damsky CH 1993 Developmental regulation of integrin expression at the time of implantation in the mouse embryo. Development 119:1175–1186[Abstract]
  12. Sutherland AE, Calarco PG, Damsky CH 1988 Expression and function of cell surface extracellular matrix receptors in mouse blastocyst attachment and outgrowth. J Cell Biol 106:1331–1348[Abstract/Free Full Text]
  13. Shiokawa S, Yoshimura Y, Nagamatsu S, Sawa H, Hanashi H, Koyama N, Katsumata Y, Nagai A, Nakamura Y 1996 Function of beta 1 integrins on human decidual cells during implantation. Biol Reprod 54:745–752[Abstract]
  14. Ruck P, Marzusch K, Kaiserling E, Horny HP, Dietl J, Geiselhart A, Handgretinger R, Redman CWG 1994 Distribution of cell adhesion molecules in decidua of early human pregnancy. An immunohistochemical study. Lab Invest 71:94–101[Medline]
  15. Maruyama T, Yoshimura Y, Yodoi J, Sabe H 1999 Activation of c-Src kinase is associated with in vitro decidualization of human endometrial stromal cells. Endocrinology 140:2632–2636[Abstract/Free Full Text]
  16. Kisalus LL, Herr JC, Little CD 1987 Immunolocalization of extracellular matrix proteins and collagen synthesis in first-trimester human decidua. Anat Rec 218:402–415[CrossRef][Medline]
  17. Glasser SR, Lampelo S, Munir MI, Julian JA 1987 Expression of desmin, laminin and fibronectin during in situ differentiation (decidualization) of rat uterine stromal cells. Differentiation 35:132–142[CrossRef][Medline]
  18. Irwin JC, Kirk D, King RJB, Quigley MM, Gwatkin RBL 1989 Hormonal regulation of human endometrial stromal cells in culture: an in vitro model for decidualization. Fertil Steril 52:761–768[Medline]
  19. Mulholland J, Aplin JD, Ayad S, Hong L, Glasser SR 1992 Loss of collagen type VI from rat endometrial stroma during decidualization. Biol Reprod 46:1136–1143[Abstract]
  20. Babiarz B, Romagnano L, Afonso S, Kurilla G 1996 Localization and expression of fibronectin during mouse decidualization in vitro: mechanisms of cell:matrix interactions. Dev Dyn 206:330–342[CrossRef][Medline]
  21. Tobe K, Sabe H, Yamamoto T, Yamauchi T, Asai S, Kaburagi Y, Tamemoto H, Ueki K, Kimura H, Akanuma Y, Yazaki Y, Hanafusa H, Kadowaki T 1996 Csk enhances insulin-stimulated dephosphorylation of focal adhesion proteins. Mol Cell Biol 16:4765–4772[Abstract]
  22. Maruyama T, Sachi Y, Furuke K, Kitaoka Y, Kanzaki H, Yoshimura Y, Yodoi J 1999 Induction of thioredoxin, a redox-active protein, by ovarian steroid hormones during growth and differentiation of endometrial stromal cells in vitro. Endocrinology 140:365–372[Abstract/Free Full Text]
  23. Minamikawa T, Takamatsu T, Fujita S 1991 Application of laser microtomography to in situ three-dimensional subcellular morphology. Acta Histochem Cytochem 24:55–60
  24. Miyazaki Y, Takamatsu T, Nosaka T, Fujita S, Hatanaka M 1992 Intranuclear topological distribution of HIV-1 trans-activators. FEBS Lett 305:1–5[CrossRef][Medline]
  25. Schlaepfer DD, Jones KC, Hunter T 1998 Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events. Mol Cell Biol 18:2571–2585[Abstract/Free Full Text]
  26. Hildebrand JD, Schaller MD, Parsons JT 1995 Paxillin, a tyrosine phosphorylated focal adhesion-associated protein binds to the carboxyl terminal domain of focal adhesion kinase. Mol Biol Cell 6:637–647[Abstract]
  27. Zachary I, Rozengurt E 1992 Focal adhesion kinase (p125FAK): a point of convergence in the action of neuropeptides, integrins, and oncogenes. Cell 71:891–894[CrossRef][Medline]
  28. Clark EA, Brugge JS 1995 Integrins and signal transduction pathways: the road taken. Science 268:233–239[Abstract/Free Full Text]
  29. Zachary I, Sinnett-Smith J, Rozengurt E 1992 Bombesin, vasopressin, and endothelin stimulation of tyrosine phosphorylation in Swiss 3T3 cells. Identification of a novel tyrosine kinase as a major substrate. J Biol Chem 267:19031–19034[Abstract/Free Full Text]
  30. Lipfert L, Haimovich B, Schaller MD, Cobb BS, Parsons JT, Brugge JS 1992 Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets. J Cell Biol 119:905–912[Abstract/Free Full Text]
  31. Chen HC, Guan JL 1994 Stimulation of phosphatidylinositol 3'-kinase association with focal adhesion kinase by platelet-derived growth factor. J Biol Chem 269:31229–31233[Abstract/Free Full Text]
  32. Matsumoto K, Matsumoto K, Nakamura T, Kramer RH 1994 Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem 269:31807–31813[Abstract/Free Full Text]
  33. Rankin S, Rozengurt E 1994 Platelet-derived growth factor modulation of focal adhesion kinase (p125FAK) and paxillin tyrosine phosphorylation in Swiss 3T3 cells. Bell-shaped dose response and cross-talk with bombesin. J Biol Chem 269:704–710[Abstract/Free Full Text]
  34. Tabibzadeh S 1991 Human endometrium: an active site of cytokine production and action. Endocr Rev 12:272–290[Medline]
  35. Giudice LC 1994 Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine. Fertil Steril 61:1–17[Medline]
  36. Lamb NJC, Fernandez A, Conti MA, Adelstein R, Glass DB, Welch WJ, Feramisco JR 1988 Regulation of actin microfilament integrity in living nonmuscle cells by the cAMP-dependent protein kinase and the myosin light chain kinase. J Cell Biol 106:1955–1971[Abstract/Free Full Text]
  37. Tang B, Guller S, Gurpide E 1993 Cyclic adenosine 3',5'-monophosphate induces prolactin expression in stromal cells isolated from human proliferative endometrium. Endocrinology 133:2197–2203[Abstract]
  38. Telgmann R, Maronde E, Taskén K, Gellersen B 1997 Activated protein kinase A is required for differentiation-dependent transcription of the decidual prolactin gene in human endometrial stromal cells. Endocrinology 138:929–937[Abstract/Free Full Text]
  39. Brar AK, Frank GR, Kessler CA, Cedars MI, Handwerger S 1997 Progesterone-dependent decidualization of the human endometrium is mediated by cAMP. Endocrine 6:301–307[Medline]
  40. Carter CA, Rinehart CA, Bagnell Jr CR, Kaufman DG 1991 Fluorescent laser scanning microscopy of F-actin disruption in human endometrial stromal cells expressing the SV40 large T antigen and the EJ ras oncogene. Pathobiology 59:36–45[CrossRef][Medline]
  41. Kim JJ, Jaffe RC, Fazleabas AT 1999 Insulin-like growth factor binding protein-1 expression in baboon endometrial stromal cells: regulation by filamentous actin and requirement for de novo protein synthesis. Endocrinology 140:997–1004[Abstract/Free Full Text]
  42. Hatayama H, Kanzaki H, Iwai M, Kariya M, Fujimoto M, Higuchi T, Kojima K, Nakayama H, Mori T, Fujita J 1994 Progesterone enhances macrophage colony-stimulating factor production in human endometrial stromal cells in vitro. Endocrinology 135:1921–1927[Abstract]



This article has been cited by other articles:


Home page
EndocrinologyHome page
T. Nagashima, T. Maruyama, H. Uchida, T. Kajitani, T. Arase, M. Ono, H. Oda, M. Kagami, H. Masuda, S. Nishikawa, et al.
Activation of SRC Kinase and Phosphorylation of Signal Transducer and Activator of Transcription-5 Are Required for Decidual Transformation of Human Endometrial Stromal Cells
Endocrinology, March 1, 2008; 149(3): 1227 - 1234.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. Ihnatovych, W. Hu, J. L. Martin, A. T. Fazleabas, P. de Lanerolle, and Z. Strakova
Increased Phosphorylation of Myosin Light Chain Prevents in Vitro Decidualization
Endocrinology, July 1, 2007; 148(7): 3176 - 3184.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Sakai, T. Maruyama, R. Sakurai, H. Masuda, Y. Yamamoto, A. Shimizu, I. Kishi, H. Asada, S. Yamagoe, and Y. Yoshimura
Involvement of Histone Acetylation in Ovarian Steroid-induced Decidualization of Human Endometrial Stromal Cells
J. Biol. Chem., May 2, 2003; 278(19): 16675 - 16682.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
Y. Yamamoto, T. Maruyama, N. Sakai, R. Sakurai, A. Shimizu, T. Hamatani, H. Masuda, H. Uchida, H. Sabe, and Y. Yoshimura
Expression and subcellular distribution of the active form of c-Src tyrosine kinase in differentiating human endometrial stromal cells
Mol. Hum. Reprod., December 1, 2002; 8(12): 1117 - 1124.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maruyama, T.
Right arrow Articles by Sabe, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maruyama, T.
Right arrow Articles by Sabe, H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals